Study the Changes in family burden after Homoeopathic medication in Schizophrenia

Changes In Family Burden After Individualized Homeopathic medication in Schizophrenia - A Prospective study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046498

Enrollment

Registered

2022-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: HOMOEOPATHIC INTERVENTION: Individualized Homoeopathic medicine is Selected according to the principles of homoeopathy Route of Administration - oral Dose- As per Requirement duratio

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both genders between 16 and 70 years of age who have fulfilled ICD 10 diagnostic criteria of schizophrenia

Exclusion criteria

Exclusion criteria: 1. Patients with substance-induced psychotic illness. 2. Patients with serious systemic illness. 3. Those cases where Family members are not willing to give consent to take part in the study

Design outcomes

Primary

Measure	Time frame
To determine the changes in family burden in schizophrenia after giving individualized homoeopathic medicineTimepoint: 1 year	—

Secondary

Measure	Time frame
To find out the corelation between improvement in schizophrenia and the reduction of family burden after individualized homoeopathic medicine using standardised rating scalesTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDrJayashree Janagam

National Homoeopathy Reasearch Institute In Mental Health

drjayajanagam@gmail.com9177709429

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026